Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Herston
Clinical trial register · Australia

Clinical Trials in Herston, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC7 Novartis Pharmaceuticals6 GlaxoSmithKline5 Amgen5 AstraZeneca4
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Herston

144 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma
NCT07739017Recurrent Glioblastoma, Newly Diagnosed MGMT Unmethylated Glioblastoma
Olivia Newton-John Cancer Research Institute
Phase 1
54
Herston, Heidelberg
2026-12
Not yet open
Novo Nordisk A/S
Phase 3
84
Camperdown, Herston, Melbourne
2026-10-09
Recruiting
VarmX B.V.
Phase 3
800
Herston, South Brisbane, Southport, Fitzroy, Melbourne, Murdoch
2026-08-18
Recruiting
Gilead Sciences
Phase 2
120
Camperdown, St Leonards, Herston, Bedford Park, Nedlands
2026-08-07
Not yet open
Yanping Kong
Phase 1
30
Herston
2026-08-01
Recruiting
VectivBio AG
Phase 3
124
Fitzroy, Heidelberg, Herston, Perth
2026-08
Recruiting
iVEAcare
Not applicable
30
Herston, South Brisbane, Clayton, Fitzroy, Heidelberg, Melbourne, Parkville
2026-07-29
Not yet open
The University of Queensland
Observational
70
Herston
2026-06-30
Recruiting
GlaxoSmithKline
Phase 3
600
Dubbo, Auchenflower, Herston
2026-06-04
Recruiting
DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
NCT07623525Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension
Diagonal Therapeutics, Inc.
Phase 1/2
93
Camperdown, Randwick, Herston, East Melbourne, Parkville, West Perth
2026-06-04
Recruiting
HB BioTech, LLC
Phase 2
200
Deakin, Charlestown, Darlinghurst, Waitara, Westmead, Herston, Mackay, Morayfield
2026-06-03
Not yet open
Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial
NCT07019610Vascular Access Complication, Device Related Infection, Device Related Sepsis, Catheter Infection
The University of Queensland
Not applicable
60
Herston
2026-06
Recruiting
Gilead Sciences
Phase 2
170
Camperdown, Herston, Melbourne
2026-05-19
Not yet open
Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company
Phase 1
45
Herston, Melbourne
2026-05-04
Recruiting
Sanofi
Phase 1
570
Griffith, Herston, Morayfield, Sippy Downs, South Brisbane, Taringa
2026-04-15
By invitation
Skyhawk Therapeutics, Inc.
Phase 2/3
500
New Lambton Heights, Westmead, Herston, Adelaide, Caulfield South, Parkville, Nedlands
2026-04-10
Recruiting
Bristol-Myers Squibb
Phase 1/2
474
North Ryde, St Leonards, Brisbane, Herston, Heidelberg, Malvern
2026-03-26
Recruiting
A Study of ORN252 in Healthy Participants
NCT07439796Healthy Volunteers - Male and Female
Orna Therapeutics, Inc.
Phase 1
20
Herston
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 2
100
St Leonards, Birtinya, Herston, Box Hill
2026-03-11
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
DrugsCetuximab·Nab-paclitaxel·Gemcitabine
Revolution Medicines, Inc.
Phase 3
900
Kogarah, Randwick, Waratah, Herston, East Melbourne, Heidelberg
2026-03-09
Recruiting
Boehringer Ingelheim
Phase 3
286
Concord, Kingswood, Kogarah, Westmead, Herston, Southport, Adelaide, AT Albans
2026-02-16
Active, closed
Kailera
Phase 3
1,270
Bruce, Blacktown, Kanwal, Herston, Morayfield, South Brisbane, Camberwell
2025-12-30
Active, closed
Amgen
Phase 3
250
Macquarie Park, Herston, Clayton
2025-12-19
Recruiting
EBR Systems, Inc.
Not applicable
40
Birtinya, Herston, Southport, Woolloongabba
2025-12-18
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
NCT07144163Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 3
150
Herston, Woolloongabba, Adelaide, Parkville, Nedlands
2025-12-11
Recruiting
AstraZeneca
Phase 2
230
Camperdown, Clayton, Herston, Melbourne, South Brisbane
2025-12-10
Recruiting
Consun Pharmaceutical Group
Phase 1
84
Herston
2025-12-08
Active, closed
Amgen
Phase 3
250
Macquarie Park, Herston, Clayton
2025-11-25
Recruiting
Ingenia Therapeutics INC
Phase 1/2
94
Herston, Gosford, Sydney, Morayfield, Saint Albans
2025-10-30
Recruiting
Study of BHV-1300 in Graves' Disease
NCT06980649Graves Disease
DrugBHV-1300
Biohaven Therapeutics Ltd.
Phase 1
15
Fitzroy, Herston, Kotara, Melbourne, Oaklands Park, Parkville, St Leonards, Torquay
2025-08-21
Active, closed
Chimivac INC
Phase 1
36
Herston
2025-08-19
Active, closed
GlaxoSmithKline
Phase 2
168
Camperdown, Birtinya, Herston
2025-08-06
Recruiting
Amgen
Phase 3
12,800
Charlestown, Darlinghurst, St Leonards, Auchenflower, Herston, Milton, Woolloongabba, Bedford Park
2025-07-25
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Clayton, Herston, Melbourne, Murdoch, St Leonards, Woodville South
2025-07-21
Recruiting
Marea Therapeutics
Phase 2
316
Canberra, Kanwal, Merewether, Miranda, Wollongong, Herston, Milton, Leabrook
2025-06-30
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Garran, Liverpool, St Leonards, Auchenflower, Birtinya, Herston, Milton, Southport
2025-06-25
Recruiting
Study of HX15001 in Adult Healthy Volunteers.
NCT06999720Healthy Volunteers
DrugHX15001
Helixon Biotechnology (Suzhou) Co., Ltd
Phase 1
62
Herston
2025-06-11
Active, closed
Skyhawk Therapeutics, Inc.
Phase 2/3
120
New Lambton Heights, Westmead, Herston, Adelaide, Launceston, Caulfield South, Parkville, Nedlands
2025-05-27
Recruiting
Biogen
Phase 3
180
Concord, Kogarah, Liverpool, Westmead, Douglas, Herston, Southport, Clayton
2025-05-22
Active, closed
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT06970847Prostate Cancer, Prostate Cancer Patients With Detectable PSA Following Prostatectomy, Prostate Cancer Recurrent, Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Drug64Cu-SAR-bisPSMA
Clarity Pharmaceuticals Ltd
Phase 3
220
Darlinghurst, Wahroonga, Westmead, Herston
2025-05-16
Recruiting
Biogen
Phase 3
454
New Lambton, New South Wales, St Leonards, Westmead, Douglas, Herston, Southport, Woolloongabba
2025-05-08
Recruiting
Capstan Therapeutics
Phase 1
64
Herston, Bayswater, Nedlands
2025-04-09
Active, closed
Generate Biomedicines
Phase 1
40
Herston
2025-03-27
Recruiting
Hoffmann-La Roche
Phase 3
600
Garran, Sydney, Herston, South Brisbane, Woolloongabba, Adelaide, Epping, Murdoch
2025-03-17
Recruiting
Novartis Pharmaceuticals
Phase 2/3
443
Darlinghurst, Herston, Melbourne
2025-02-27
Recruiting
Supernus Pharmaceuticals, Inc.
Phase 2
216
Herston, Adelaide, Clayton, Fitzroy, Melbourne, Parkville, Nedlands
2024-12-30
Active, closed
Coherus Oncology, Inc.
Phase 2
72
Herston, Bankstown, Melbourne, Darlinghurst, Nedlands
2024-12-20
Recruiting
GlaxoSmithKline
Phase 3
520
Gosford NSW, Box Hill, Melbourne, Fitzroy, Herston, St Leonards
2024-12-16
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 2
130
Herston, Nedlands, North Ryde, Parkville
2024-12-06
Recruiting
BMB-101 in Absence Epilepsy and DEE
NCT06401538Absence Epilepsy, Jeavons Syndrome, Dravet Syndrome, Lennox Gastaut Syndrome
DrugBMB-101
Bright Minds Biosciences Pty Ltd
Phase 2
20
Randwick, Herston, Fitzroy, Heidelberg, Melbourne
2024-12-05
Recruiting
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06637332Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia, S. Aureus Bloodstream Infection
DrugsDaptomycin·Vancomycin
Todd C. Lee MD MPH FIDSA
Phase 4
300
Blacktown, Concord, Newcastle, Westmead, Herston, Bedford Park, Berwick, Box Hill
2024-11-14
Active, closed
Eli Lilly and Company
Phase 3
1,400
Birtinya, Botany, Box Hill, Camberwell, East Maitland, Herston, Ipswich, Ivanhoe
2024-10-24
Active, closed
Abcuro, Inc.
Phase 2/3
270
Saint Leonards, Herston, Nedlands
2024-10-21
Active, closed
Novartis Pharmaceuticals
Phase 2
251
North Ryde, Herston, Caulfield South, Southport
2024-10-17
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Broadmeadow, Coffs Harbour, Kingswood, Liverpool, Westmead, Herston, Adelaide, Box Hill
2024-10-04
Active, closed
ModernaTX, Inc.
Phase 3
37,864
Bruce, Coffs Harbour, Darlinghurst, Kanwal, Maroubra, Herston, Southport, Norwood
2024-09-24
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
130
Camperdown, Herston, Adelaide, Melbourne
2024-09-11
Recruiting
Inventage Lab., Inc.
Phase 1
40
Herston
2024-09-11
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-07-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Sydney, Herston, Clayton, Melbourne, Nedlands
2024-07-24
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Bedford Park, Herston, Kurralta Park, Melbourne, Perth, Woolloongabba, QLD
2024-07-18
Active, closed
Merus B.V.
Phase 3
621
Darlinghurst, Herston, Melbourne, Nedlands, Saint Leonards, Sydney
2024-06-25
Active, closed
Dynavax Technologies Corporation
Phase 1/2
764
Blacktown, Botany, Brookvale, Kanwal, Miranda, Waitara, Wollongong, Herston
2024-06-17
Recruiting
Western Sydney Local Health District
Phase 2
160
Westmead, Herston, Parkdale, Parkville, Nedlands
2024-06-01
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Adelaide, Fitzroy, Greenslopes, Heidelberg, Herston, Murdoch, Perth, South Brisbane
2024-05-24
Recruiting
Peter MacCallum Cancer Centre, Australia
Phase 2
40
Camperdown, Westmead, Herston, Melbourne, Murdoch
2024-05-14
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Camperdown, Randwick, Herston, Fitzroy, Heidelberg, Melbourne, Parkville, Bedford Park
2024-05-13
Recruiting
A Platform Trial for Gram Negative Bloodstream Infections
NCT06537609Gram-negative Bacteremia
Sunnybrook Health Sciences Centre
Not applicable
2,500
Kogarah, New Lambton, Herston, Redcliffe, Sunshine Coast, Clayton, Murdoch
2024-04-24
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Canberra, Clayton, Concord, Herston, Liverpool, Perth, Southport, St Albans
2024-03-29
Recruiting
GlaxoSmithKline
Phase 3
864
Blacktown, Douglas, Herston, Ballarat, Geelong, Melbourne
2024-03-21
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Brisbane, Herston, South Brisbane, Adelaide, Bedford Park, Clayton, Heidelberg, Perth
2024-03-13
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Darlinghurst, Herston, Adelaide, Malvern
2024-03-12
Recruiting
Ontario Clinical Oncology Group (OCOG)
Observational
352
Cudgen, Liverpool, North Sydney, Westmead, Herston, Woolloongabba, Bentleigh East, East Melbourne
2024-03-12
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Liverpool, Birtinya, Herston, Melbourne, South Brisbane
2024-03-04
Active, closed
Cynata Therapeutics Limited
Phase 2
60
Sydney, Westmead, Herston
2024-03-04
Active, closed
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
NCT06157541Glioblastoma Multiforme, Astrocytoma, Grade IV
DrugsKeytruda·Pembrolizumab
Queensland Institute of Medical Research
Phase 1/2
58
Bowen Hills, Herston, Woolloongabba, Heidelberg
2024-02-08
Active, closed
CAMP4 Therapeutics Corporation
Phase 1
120
Herston
2024-02-05
Active, closed
Genmab
Phase 3
1,095
Camperdown, Liverpool, Melbourne, Westmead, Douglas, Herston, Woolloongabba, Frankston
2024-02-05
Active, closed
Astellas Gene Therapies
Not applicable
119
Adelaide, Herston
2024-02-01
Recruiting
CSL Behring
Phase 3
35
Camperdown, Herston, Adelaide, Melbourne
2024-01-30
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
124
Clayton, Herston, Parkville, St Leonards
2024-01-03
Active, closed
A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)
NCT05784441Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC
Phase 1
21
Camperdown, Clayton, Heidelberg, Herston, Westmead
2023-11-06
Active, closed
Stichting European Myeloma Network
Phase 3
759
Brisbane, Camperdown, Herston, Melbourne, Murdoch, Waratah, Westmead
2023-10-10
Active, closed
Incyte Corporation
Phase 1
160
Herston, Adelaide, Melbourne
2023-09-25
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Concord, Darlinghurst, Macquarie University, North Ryde, Randwick, Brisbane, Chermside, Herston
2023-09-22
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Camperdown, St Leonards, Auchenflower, Herston, Adelaide, Hobart, Launceston, Fitzroy
2023-09-18
Recruiting
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
NCT05303519Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma, Astrocytoma, IDH-Mutant, Grade 3
DrugSafusidenib
Nuvation Bio Inc.
Phase 3
365
Darlinghurst, Saint Leonards, Herston, Melbourne, Nedlands
2023-06-05
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Adelaide, Brisbane, Concord, Frankston, Garran, Herston, Joondalup, Kotara
2023-04-11
Recruiting
Vega Therapeutics, Inc
Phase 1/2
116
Herston
2023-03-16
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Adelaide, Box Hill, Campbelltown, Camperdown, Clayton, Fitzroy, Heidelberg, Herston
2023-02-15
Active, closed
Australasian Gastro-Intestinal Trials Group
Phase 2
38
Saint Leonards, Sydney, Westmead, Herston, Adelaide, Bedford Park, Ballarat Central, Box Hill
2023-01-23
Recruiting
Jazz Pharmaceuticals
Phase 3
510
Randwick, Sydney, Herston, Hobart, Heidelberg, Nedlands
2023-01-23
Active, closed
Calcilytix Therapeutics, Inc., a BridgeBio company
Phase 3
67
Saint Leonards, Herston
2023-01-06
By invitation
BioMarin Pharmaceutical
Observational
172
Sydney, Herston, Adelaide, Melbourne, Murdoch
2023-01-01
Active, closed
Monash University
Phase 3
960
Darlinghurst, Randwick, Westmead, Herston, Woolloongabba, Adelaide, Clayton, Fitzroy
2022-12-01
Recruiting
The University of Queensland
Phase 3
1,174
Gosford, Sydney, Bundaberg, Douglas, Herston, Woolloongabba, Adelaide, Melbourne
2022-11-29
Active, closed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
NCT05611671Inflammatory Bowel Diseases, Colitis, Ulcerative
DrugZotemtegrast
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
280
Blacktown, Concord, Herston, Murdoch, South Brisbane
2022-11-21
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Adelaide, Camperdown, Clayton, Herston, Murdoch, Parkville, South Brisbane, Woodville South
2022-09-13
Active, closed
AstraZeneca
Phase 2
194
Darlinghurst, East Melbourne, Herston, Woolloongabba
2022-08-11
Recruiting
Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma
NCT05025813Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Cancer
DrugPembrolizumab
Queensland Health
Phase 2
27
Camperdown, Herston, Woolloongabba
2022-06-28
By invitation
UCB Biopharma SRL
Phase 3
300
Fitzroy, Herston, South Brisbane
2022-02-03
Active, closed
GlaxoSmithKline
Phase 2
360
Herston, Fitzroy
2021-12-14
Recruiting
Australasian Gastro-Intestinal Trials Group
Phase 2
54
Garran, Albury, Newcastle, Herston, Bedford Park, Fitzroy, Melbourne, Nedlands
2021-12-08
Recruiting
UCB Biopharma SRL
Phase 3
350
Fitzroy, Herston, Melbourne, South Brisbane
2021-12-07
Active, closed
Amgen
Phase 3
303
Garran, Camperdown, Liverpool, St Leonards, Westmead, Herston, Woolloongabba, Adelaide
2021-11-02
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Camperdown, Fitzroy, Heidelberg, Herston, Melbourne, Murdoch, Waratah, Westmead
2021-08-19
Active, closed
Inventiva Pharma
Phase 3
1,000
Concord, Liverpool, Penrith, Greenslopes, Herston, Box Hill, Clayton, Heidelberg
2021-08-19
Active, closed
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA
NCT04319783Advanced Prostate Carcinoma, Cancer of Prostate, PSA, Castrate Resistant Prostate Cancer
DrugDarolutamide
Trans Tasman Radiation Oncology Group
Phase 2
65
Darlinghurst, Hurstville, Saint Leonards, Waratah, Herston, Raymond Terrace, Woolloongabba, Adelaide
2021-06-02
Active, closed
ALX Oncology Inc.
Phase 2
172
Herston, Adelaide, Melbourne, Nedlands
2021-05-10
Active, closed
Geron Corporation
Phase 3
327
St Leonards, Herston, Hobart, Richmond
2021-04-12
Active, closed
Atrasentan in Patients With Proteinuric Glomerular Diseases
NCT04573920IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease
DrugAtrasentan
Novartis Pharmaceuticals
Phase 2
103
Gosford, Herston, Clayton, Reservoir, St Albans, St Leonards
2021-03-15
Recruiting
Sentinel Node Biopsy in Endometrial Cancer
NCT04073706Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery
Queensland Centre for Gynaecological Cancer
Phase 3
760
Camperdown, Liverpool, Auchenflower, Brisbane, Buderim, Everton Park, Herston, South Brisbane
2021-01-18
Active, closed
Pfizer
Phase 3
841
Camperdown, Liverpool, St Leonards, Herston, Woolloongabba, Adelaide, Clayton, Heidelberg
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Birtinya, Darlinghurst, Herston, Hobart, Kurralta Park, Liverpool, Melbourne, Murdoch
2020-09-23
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Adelaide, Camperdown, Herston, Melbourne, Murdoch
2020-06-12
Active, closed
University of Sydney
Phase 3
1,100
Albury, Gosford, Newcastle, Nowra, Sydney, Wollongong, Brisbane, Herston
2020-03-31
Active, closed
Bristol-Myers Squibb
Phase 3
790
Waratah, Westmead, Wollstonecraft, Cairns, Greenslopes, Herston, Southport, Box Hill
2019-10-28
Active, closed
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
NCT05586750Dementia, Mixed, Dementia, Vascular, Dementia of Alzheimer Type, Cognitive Decline
DrugAtorvastatin
Monash University
Phase 4
341
Herston, Clayton
2019-09-19
Recruiting
Global Coalition for Adaptive Research
Phase 2/3
2,250
St Leonards, Waratah, Herston, Bedford Park, Heidelberg, Melbourne
2019-07-30
Active, closed
Pfizer
Phase 3
51
Camperdown, Adelaide, Melbourne, Murdoch, Herston
2019-07-29
Active, closed
Long Term Extension Study in Patients With Primary Hyperoxaluria
NCT04042402Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases, Urologic Diseases
DrugDcr-Phxc
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Phase 3
75
Herston, Melbourne
2019-07-09
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Camperdown, Darlinghurst, Kingswood, New Lambton, Westmead, Herston, South Brisbane, Adelaide
2019-03-28
Active, closed
AbbVie
Phase 3
964
Garran, Herston, Maroochydore, Southport, Bedford Park, Camberwell, Clayton
2019-03-25
Recruiting
Aptose Biosciences Inc.
Phase 1/2
240
Albury, Herston, Townsville, Fitzroy, Nedlands
2019-03-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Westmead, Herston
2018-12-17
Active, closed
AstraZeneca
Phase 3
724
Benowa, Box Hill, Camperdown, Clayton, Herston, Liverpool, Melbourne
2018-11-30
Active, closed
AstraZeneca
Phase 3
895
Box Hill, Darlinghurst, Greenslopes, Herston, Kingswood, Kurralta Park, St Albans, Waratah
2018-10-31
Active, closed
Exelixis
Phase 3
187
St Leonards, Waratah, Bedford Park, Melbourne, Herston
2018-10-05
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Clayton, Concord, Fitzroy, Herston, Hobart, Kogarah, Malvern, Nedlands
2018-06-26
Active, closed
Bristol-Myers Squibb
Phase 3
545
Blacktown, Camperdown, Concord, Herston, Adelaide, Heidelberg, Nedlands
2018-04-18
Active, closed
Gilead Sciences
Phase 3
340
Herston, Melbourne, Parkville
2017-12-12
Active, closed
BeiGene
Phase 3
590
Concord, Cudgen, Waratah, Westmead, Auchenflower, Brisbane, Herston, Adelaide
2017-10-31
Recruiting
Prostate Cancer Clinical Trials Consortium
Observational
5,000
Herston, Darlinghurst, Sydney, Cleveland, Woolloongabba, Box Hill, Melbourne, Mount Waverley
2017-07-21
Active, closed
Acerta Pharma BV
Phase 3
635
Bedford Park, Concord, Frankston, Gosford, Heidelberg, Herston, Kogarah, Murdoch
2017-04-05
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Camperdown, Melbourne, Parkville, Murdoch, Herston
2015-11-02
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Darlinghurst, Herston, Wooloongabba, Bedford Park, Box Hill, Clayton, Franston, Perth
2015-03-05
Active, closed
Exelixis
Phase 4
247
St Leonards, Herston, Kurralta Park, Parkville
2015-02-25
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Clayton, Parkville, Herston, South Brisbane
2015-01-20
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Adelaide, Ashford, Camperdown, Herston, Liverpool, Malvern, Melbourne, Southport
2014-11-26
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 3
789
Bankstown, Kingswood, Kogarah, Randwick, Waratah, Douglas, Herston, Woolloongabba
2014-04
Active, closed
AbbVie
Observational
8,250
Garran, Camperdown, Concord, East Lismore, New Lambton, Herston, South Brisbane, Adelaide
2013-04-29
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Westmead, Cairns, Herston, Woolloongabba, Adelaide, Heidelberg, Parkville, Murdoch
2013-03-18
Recruiting
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT02493478Failed or Difficult Intubation, Sequela, Intubation; Difficult, Intubation Complication
Children's Hospital of Philadelphia
Observational
150,000
Herston, Parkville
2010-03
Active, closed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
10,273
Albury, Coffs Harbour, Concord, Lismore, Merewether, Newcastle, Waratah, Herston
2006-04-07
Rows per page Showing 1–144 of 144
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/herston

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 144 of those studies with a site in Herston.

How many clinical trials are recruiting in Herston?

63 of the 144 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 6 have not yet opened recruitment, 69 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Herston), 144 studies
PhaseStudiesRecruitingShare
Phase 3692547.9%
Phase 2261418.1%
Phase 115710.4%
Phase 1/21066.9%
Observational845.6%
Phase 2/3734.9%
Not applicable533.5%
Phase 4412.8%

Most active sponsors

Lead sponsors with the most studies (Herston)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC70
Novartis Pharmaceuticals63
Amgen52
GlaxoSmithKline53
Alexion Pharmaceuticals, Inc.41
AstraZeneca41
Biohaven Therapeutics Ltd.31
Bristol-Myers Squibb31
Exelixis31
Gilead Sciences32
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.